First reported at 1,705,351 shares this quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2026-09-30 | 25631426 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | New | 1,705,351 | +1,705,351 (0.0%) | 1.02% | $25,631,426 | 2026-11-16 |
Who else reported the position
348 managers reported ULTRAGENYX PHARMACEUTICAL IN for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BlackRock Inc | Added | 11,432,853 | +778,577 | < 0.01% | $171,835,781 | 9 qtrs |
| RTW INVESTMENTS LP | Added | 8,529,394 | +732,499 | 1.29% | $128,196,792 | 20 qtrs |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Added | 8,419,105 | +1,628,970 | < 0.01% | $126,539,148 | 3 qtrs |
| STATE STREET CORPORATION | Added | 7,538,078 | +1,379,312 | < 0.01% | $113,297,312 | 51 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Added | 4,299,168 | +2,677 | < 0.01% | $64,616,495 | 3 qtrs |
| TWO SIGMA INVESTMENTS LP | Reduced | 3,130,527 | -490,673 | 0.03% | $47,051,821 | 26 qtrs |
| JACOBS LEVY EQUITY MANAGEMENT INC | Reduced | 2,900,418 | -39,301 | 0.15% | $43,593,283 | 6 qtrs |
| Nantahala Capital Management LLC | New | 2,339,293 | +2,339,293 | 1.11% | $35,159,574 | 1 qtr |
| GW&K Investment Management LLC | Added | 2,307,844 | +826,666 | 0.29% | $34,687,000 | 15 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Reduced | 2,174,052 | -404,776 | < 0.01% | $32,683,698 | 51 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 16, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 1,705,351
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.